The ‘Magnificent Seven’ is now the ‘Lag 7.’ How Big Tech’s slump is dragging down the S&P 500.
A breakdown of the “Magnificent Seven” and AI hyperscalers raises concern for the stock market and the economy View Source Cam Hui MarketWatch.com – Top…
Category: MarketWatch
How Lowe’s stock has trounced Home Depot’s — and what may lie ahead
The hardware and home-furnishings rivals will both report quarterly results this week. View Source Philip van Doorn MarketWatch.com – Top Stories February 23, 2026 5:28…
Gilead shows its belief in its partner’s cancer treatment with a $7.8 billion buyout
Arcellx’s stock is heading toward a record after the $7.8 billion deal to be acquired by Gilead. View Source Tomi Kilgore MarketWatch.com – Top Stories…
There’s another AI-doom post doing the rounds. This time, the S&P 500 dives nearly 40%.
A booming AI economy may be very bad for the broader economy, according to Citrini Research View Source Jamie Chisholm MarketWatch.com – Top Stories February…
‘I found out too late’: My stepmother cheated me out of $500K from my father’s estate. What can I do?
“Within a week or two after the deadline to contest the will expired, my stepmother sent me an email stating she would not share anything.”…
Here are the five companies that $9 trillion of funds agree on right now
Vertiv has been a top holding among hedge and mutual funds in the first quarter of this year so far, and a lucrative one. View…
Novo Nordisk pitted a new weight-loss drug against Eli Lilly’s — and lost
Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn’t cut as…
‘I spend $7,500 a month’: I’m 47, earn $260K, and have $3 million. Can I retire at 50?
“I own a home worth $520,000 and do not have a mortgage on it.” View Source Quentin Fottrell MarketWatch.com – Top Stories February 23, 2026…
Why JPMorgan says the international stock story still has legs
Decent growth, benign inflation, a dovish Fed and a weaker dollar all favor equities but international and emerging stocks look set to build on the…
Novo Nordisk pitted a new weight-loss drug against Eli Lilly — and lost
Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn’t cut as…